5-76732339-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001992.5(F2R):āc.114A>Gā(p.Leu38=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00293 in 1,605,272 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0027 ( 5 hom., cov: 32)
Exomes š: 0.0030 ( 45 hom. )
Consequence
F2R
NM_001992.5 synonymous
NM_001992.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0490
Genes affected
F2R (HGNC:3537): (coagulation factor II thrombin receptor) Coagulation factor II receptor is a 7-transmembrane receptor involved in the regulation of thrombotic response. Proteolytic cleavage leads to the activation of the receptor. F2R is a G-protein coupled receptor family member. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 5-76732339-A-G is Benign according to our data. Variant chr5-76732339-A-G is described in ClinVar as [Benign]. Clinvar id is 714950.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.049 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00295 (4288/1452958) while in subpopulation MID AF= 0.0261 (149/5698). AF 95% confidence interval is 0.0227. There are 45 homozygotes in gnomad4_exome. There are 2153 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 414 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
F2R | NM_001992.5 | c.114A>G | p.Leu38= | synonymous_variant | 2/2 | ENST00000319211.5 | |
F2R | NM_001311313.2 | c.-250A>G | 5_prime_UTR_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
F2R | ENST00000319211.5 | c.114A>G | p.Leu38= | synonymous_variant | 2/2 | 1 | NM_001992.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00272 AC: 414AN: 152196Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
414
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00355 AC: 860AN: 242302Hom.: 10 AF XY: 0.00359 AC XY: 471AN XY: 131126
GnomAD3 exomes
AF:
AC:
860
AN:
242302
Hom.:
AF XY:
AC XY:
471
AN XY:
131126
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00295 AC: 4288AN: 1452958Hom.: 45 Cov.: 31 AF XY: 0.00298 AC XY: 2153AN XY: 721962
GnomAD4 exome
AF:
AC:
4288
AN:
1452958
Hom.:
Cov.:
31
AF XY:
AC XY:
2153
AN XY:
721962
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00272 AC: 414AN: 152314Hom.: 5 Cov.: 32 AF XY: 0.00281 AC XY: 209AN XY: 74486
GnomAD4 genome
AF:
AC:
414
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
209
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at